Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 18001-18050 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06242834
Pembrolizumab and Tazemetostat to Overcome Immune Tolerance Following ASCT or CAR T-cell Therapy in Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
PHASE2Recruiting
32 participants
Started: Sep 30, 2024 · Completed: Nov 24, 2028
1 condition2 sponsors1 location
NCT05682417
Impact of Body Schema Distortion on Remission and Weight Regain in Anorexia Nervosa
NARecruiting
42 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06473779
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
PHASE3Recruiting
300 participants
Started: Sep 30, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors85 locations
NCT06813573
Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma
NARecruiting
50 participants
Started: Sep 30, 2024 · Completed: Oct 31, 2029
2 conditions1 sponsor1 location
NCT06863857
Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal Cancer
N/ARecruiting
50 participants
Started: Sep 30, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor2 locations
NCT07072702
Feasibility and Acceptability of an Evidence-Informed Virtual Intervention to Reduce Perceptions of Injustice Following Work Injury
NARecruiting
75 participants
Started: Sep 30, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06451952
Virtual Darkness Theraphy for Agitation in Dementia
NARecruiting
72 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06740097
Feasibility of Aspirate Tissue Monitoring in Neuro-oncological Surgery
NARecruiting
50 participants
Started: Sep 30, 2024 · Completed: Sep 1, 2028
1 condition4 sponsors3 locations
NCT06984276
Ultrasound Guided Bilateral Pectoral Nerve Block Versus Bilateral Transverse Thoracic Plane Block In Pediatric Patients Undergoing Corrective Cardiac Surgeries Requiring Cardiopulmonary Bypass Via Median Sternotomy
NARecruiting
81 participants
Started: Sep 30, 2024 · Completed: Dec 30, 2025
7 conditions1 sponsor1 location
NCT05144516
Cancer and Mild Cognitive Impairment Dyadic Intervention
NARecruiting
80 participants
Started: Sep 30, 2024 · Completed: Aug 31, 2027
2 conditions1 sponsor1 location
NCT06736756
Impact of Tensor Fascia Lata Stretch on Vastus Medialis Obliqus Activity
N/ARecruiting
37 participants
Started: Sep 30, 2024 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT06414434
BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma
PHASE1Recruiting
24 participants
Started: Sep 30, 2024 · Completed: Jun 1, 2027
7 conditions2 sponsors2 locations
NCT07169097
Study of the Pharmacokinetics of Ceftriaxone
N/ARecruiting
300 participants
Started: Sep 30, 2024 · Completed: May 1, 2027
1 condition1 sponsor1 location
NCT06509191
The Use of Melatonin for Delirium Prevention in Medically Hospitalized Patients
PHASE2/PHASE3Recruiting
240 participants
Started: Sep 30, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor2 locations
NCT06718127
Description of the Immune Response to Yellow Fever Vaccination
NARecruiting
38 participants
Started: Sep 30, 2024 · Completed: Apr 30, 2027
2 conditions1 sponsor1 location
NCT07099599
Image Detection of Impaired Microcirculatory Reperfusion
N/ARecruiting
40 participants
Started: Sep 30, 2024 · Completed: Mar 31, 2027
2 conditions2 sponsors1 location
NCT06256744
Resistance Exercise-induced Anabolism in Youths and Adults
NARecruiting
60 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT06694441
Noradrenergic Dysregulation, Sleep and Cognition in Older Adults with Insomnia
NARecruiting
60 participants
Started: Sep 30, 2024 · Completed: Aug 31, 2029
1 condition2 sponsors1 location
NCT06643403
Age-related Changes in Retinal Oxygen Extraction in Healthy Subjects
NARecruiting
50 participants
Started: Sep 30, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06460155
CompuFlo CathCheck
PHASE4Recruiting
50 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06521710
Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical Prostatectomy
NARecruiting
10 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2027
2 conditions1 sponsor2 locations
NCT06487897
Phase III Presbyopia Correction Using the VIS Opti-K™ System
PHASE3Recruiting
75 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor4 locations
NCT06472661
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
EARLY_PHASE1Recruiting
11 participants
Started: Sep 30, 2024 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT06456567
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)
PHASE3Recruiting
350 participants
Started: Sep 30, 2024 · Completed: May 31, 2027
1 condition1 sponsor4 locations
NCT06466746
The Impact of Faba Bean Rich Bread on Iron Status, Postprandial Lipaemia and Satiety
NARecruiting
16 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2025
3 conditions3 sponsors1 location
NCT06600815
Analgesic Efficacy of Preemptive Stepwise Infiltration Anesthesia for Perioperative Analgesia After TKA
NARecruiting
110 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06599112
Clinical and Radiographic Evaluation of Implant Stability in Healed Maxillary Posterior Sites Comparing Osteotome, Osseodensification and Conventional Drilling Implant Placement Techniques
NARecruiting
36 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06588764
Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy
NARecruiting
50 participants
Started: Sep 30, 2024 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT06214689
IDH1 and OCT4 in High Grade Astrocytoma
N/ARecruiting
35 participants
Started: Sep 30, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06600737
Greater Manchester CARDIOvascular Pathology in Immune-Mediated Inflammatory Diseases
N/ARecruiting
325 participants
Started: Sep 30, 2024 · Completed: Sep 1, 2032
2 conditions1 sponsor1 location
NCT06992622
Zhejiang Adolescent Spine and Vision Health Cohort: A Longitudinal Database Analysis
N/ARecruiting
73,000 participants
Started: Sep 30, 2024 · Completed: Dec 30, 2032
3 conditions1 sponsor1 location
NCT06596993
Developing a Balance Rehabilitation System for Older Adults, Based on IMU and AI: Personalized Training and Preventive Strategies
NARecruiting
120 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06267911
Rehabilitation Gaming System for Intensive Care Units
NARecruiting
80 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2026
1 condition4 sponsors3 locations
NCT06421636
A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body
PHASE2Recruiting
95 participants
Started: Sep 30, 2024 · Completed: Jan 24, 2028
1 condition1 sponsor22 locations
NCT06551142
A Study of GSK5764227 in Participants With Advanced Solid Tumors
PHASE1Recruiting
316 participants
Started: Sep 30, 2024 · Completed: May 19, 2027
1 condition1 sponsor42 locations
NCT06361940
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
PHASE2Recruiting
100 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06740799
Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment
PHASE1Recruiting
12 participants
Started: Sep 30, 2024 · Completed: Mar 1, 2026
1 condition1 sponsor3 locations
NCT06091527
Treating Major Depression With Yoga Mono-therapy
NARecruiting
180 participants
Started: Sep 30, 2024 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05888233
Allopurinol Improves Heart Function in African Americans With Resistant Hypertension
PHASE2Recruiting
50 participants
Started: Sep 30, 2024 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT06496386
Robotic Assisted Major Lung Resection in Elderly Patients
N/ARecruiting
386 participants
Started: Sep 30, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor2 locations
NCT06293300
Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)
PHASE2Recruiting
50 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT06722742
Use of Iv Tramadol and Ketamine for Prevention of Post Spinal Anesthesia Shivering
PHASE3Recruiting
250 participants
Started: Sep 30, 2024 · Completed: Jan 30, 2025
1 condition1 sponsor3 locations
NCT06908746
Efficacy and Safety of Citrate Anticoagulation in CRRT for Patients With Liver Failure/DysfuncTION, the CAUTION Trial! A Retrospective Study on Etiology of Liver Failure and Their Complications
N/ARecruiting
100 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06592274
A Phase 2 Study of HB0017 in Psoriasis Patients
PHASE2Recruiting
200 participants
Started: Sep 30, 2024 · Completed: Jan 30, 2026
1 condition1 sponsor18 locations
NCT06516588
tDCS for Post-Stroke Cognitive Impairment
PHASE2Recruiting
80 participants
Started: Sep 30, 2024 · Completed: Jun 30, 2027
2 conditions2 sponsors1 location
NCT06523673
Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer
PHASE3Recruiting
104 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2027
3 conditions1 sponsor1 location
NCT06516289
Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± Camrelizumab
PHASE2Recruiting
130 participants
Started: Sep 30, 2024 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT06623396
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
PHASE1Recruiting
18 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2028
8 conditions1 sponsor7 locations
NCT05663515
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
N/ARecruiting
24,000 participants
Started: Sep 30, 2024 · Completed: Mar 2, 2026
1 condition2 sponsors8 locations
NCT06664112
Delivery Outcomes by AIDA (Artificial Intelligence Dystocia Algorithm) Analysis
N/ARecruiting
1,000 participants
Started: Sep 30, 2024 · Completed: Jun 30, 2026
6 conditions1 sponsor2 locations